Clinical Trial Update: Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT) [Phase 3]

View source ↗

Summary

The GAIT Phase 3 clinical trial evaluating glucosamine and chondroitin for osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Chondroitin sulfate (chondroitin sulfate)
• Glucosamine sulfate (glucosamine sulfate)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED